 BEVERLY, Mass., Feb. 12, 2021 GLOBE NEWSWIRE -- LexaGene Holdings, Inc., TSX-V: LXG; OTCQB: LXXGF the Company, a molecular diagnostics company that develops fully automated rapid pathogen detection systems, announces that Mr. Daryl Rebeck will resign from the Board and his position as the President of the Company effective February 15, 2021, and Stephen J. Mastrocola has joined LexaGenes Board of Directors. 